FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386765327> ?p ?o ?g. }

• W4386765327 abstract "Abstract BACKGROUND To determine to the activity and safety of TGF-β inhibitor, vactosertib in combination with imatinib in patients with desmoid tumors. PATIENTS AND METHODS In this investigator-initiated, open-label, multicenter, phase I/II trial, patients with desmoid tumors not amendable to locoregional therapies (surgery and/or radiotherapy) or with disease progression following at least one treatment were enrolled. Participants were administered 400 mg imatinib daily in combination with vactosertib (5 days on and 2 days off, twice a day) every 28 days. In phase I, the vactosertib dose was set at 100 mg (level − 1) and 200 mg (level 1) to determine the recommended phase II dose. Phase II assessed the efficacy, with the primary endpoint being progression-free rate (PFR) at 16 weeks. The tolerability of the vactosertib and imatinib combination and pharmacokinetic parameters were also evaluated. RESULTS Twenty-eight patients were enrolled with a median follow-up of 20.7 months. Of the 27 patients evaluated, 7 (25.9%) achieved a confirmed partial response and 19 (70.4%) were stable. The PFR at 16 weeks and 1 year were 96.3% and 81.0%, respectively. Treatment-naïve patients had longer PFS compared to those with 1–2 or 3 prior treatment modalities (1 year PFS 100% vs 90% vs 25%, P = 0.017). The most toxicities were mild to moderate myalgia (n = 10, 37%), anemia (n = 10, 37%), and nausea (n = 9, 33.3%). Common grade 3–4 toxicities included neutropenia (n = 6, 22.2%) and anemia (n = 5, 18.5%). CONCLUSIONS Vactosertib and imatinib combination was well-tolerated, with promising clinical activity in patients with progressive, locally advanced desmoid tumors. This is the first study investigating a novel target agent, a TGF-β inhibitor, in this rare and difficult-to-treat desmoid tumor." @default.
• W4386765327 created "2023-09-16" @default.
• W4386765327 creator A5001513584 @default.
• W4386765327 creator A5002034433 @default.
• W4386765327 creator A5007992707 @default.
• W4386765327 creator A5014693731 @default.
• W4386765327 creator A5019406140 @default.
• W4386765327 creator A5026715008 @default.
• W4386765327 creator A5027790698 @default.
• W4386765327 creator A5031582454 @default.
• W4386765327 creator A5046647594 @default.
• W4386765327 creator A5049234658 @default.
• W4386765327 creator A5061924691 @default.
• W4386765327 creator A5066288882 @default.
• W4386765327 creator A5070060016 @default.
• W4386765327 creator A5083550513 @default.
• W4386765327 creator A5084782886 @default.
• W4386765327 creator A5085642896 @default.
• W4386765327 date "2023-09-15" @default.
• W4386765327 modified "2023-09-26" @default.
• W4386765327 title "Clinical activity of TGF-β inhibitor vactosertib in combination with imatinib in desmoid tumors: a multicenter phase 1/2 study" @default.
• W4386765327 cites W1760215417 @default.
• W4386765327 cites W1967476317 @default.
• W4386765327 cites W2012130219 @default.
• W4386765327 cites W2019607817 @default.
• W4386765327 cites W2030828861 @default.
• W4386765327 cites W2050858148 @default.
• W4386765327 cites W2053453318 @default.
• W4386765327 cites W2053755159 @default.
• W4386765327 cites W2106365164 @default.
• W4386765327 cites W2111303440 @default.
• W4386765327 cites W2119274552 @default.
• W4386765327 cites W2123106337 @default.
• W4386765327 cites W2126905872 @default.
• W4386765327 cites W2134318552 @default.
• W4386765327 cites W2134595031 @default.
• W4386765327 cites W2159154806 @default.
• W4386765327 cites W2171352366 @default.
• W4386765327 cites W2172546656 @default.
• W4386765327 cites W2210053200 @default.
• W4386765327 cites W2230066740 @default.
• W4386765327 cites W2296375360 @default.
• W4386765327 cites W2312646625 @default.
• W4386765327 cites W2613374109 @default.
• W4386765327 cites W2669144980 @default.
• W4386765327 cites W2905567470 @default.
• W4386765327 cites W2906835496 @default.
• W4386765327 cites W2937823726 @default.
• W4386765327 cites W2958406986 @default.
• W4386765327 cites W2962569164 @default.
• W4386765327 cites W2963740442 @default.
• W4386765327 cites W2966469274 @default.
• W4386765327 cites W4220831425 @default.
• W4386765327 cites W4240674932 @default.
• W4386765327 cites W4323532421 @default.
• W4386765327 doi "https://doi.org/10.21203/rs.3.rs-3346056/v1" @default.
• W4386765327 hasPublicationYear "2023" @default.
• W4386765327 type Work @default.
• W4386765327 citedByCount "0" @default.
• W4386765327 crossrefType "posted-content" @default.
• W4386765327 hasAuthorship W4386765327A5001513584 @default.
• W4386765327 hasAuthorship W4386765327A5002034433 @default.
• W4386765327 hasAuthorship W4386765327A5007992707 @default.
• W4386765327 hasAuthorship W4386765327A5014693731 @default.
• W4386765327 hasAuthorship W4386765327A5019406140 @default.
• W4386765327 hasAuthorship W4386765327A5026715008 @default.
• W4386765327 hasAuthorship W4386765327A5027790698 @default.
• W4386765327 hasAuthorship W4386765327A5031582454 @default.
• W4386765327 hasAuthorship W4386765327A5046647594 @default.
• W4386765327 hasAuthorship W4386765327A5049234658 @default.
• W4386765327 hasAuthorship W4386765327A5061924691 @default.
• W4386765327 hasAuthorship W4386765327A5066288882 @default.
• W4386765327 hasAuthorship W4386765327A5070060016 @default.
• W4386765327 hasAuthorship W4386765327A5083550513 @default.
• W4386765327 hasAuthorship W4386765327A5084782886 @default.
• W4386765327 hasAuthorship W4386765327A5085642896 @default.
• W4386765327 hasBestOaLocation W43867653271 @default.
• W4386765327 hasConcept C126322002 @default.
• W4386765327 hasConcept C141071460 @default.
• W4386765327 hasConcept C197934379 @default.
• W4386765327 hasConcept C203092338 @default.
• W4386765327 hasConcept C2777054765 @default.
• W4386765327 hasConcept C2777063308 @default.
• W4386765327 hasConcept C2777583451 @default.
• W4386765327 hasConcept C2778248108 @default.
• W4386765327 hasConcept C2778375690 @default.
• W4386765327 hasConcept C2778729363 @default.
• W4386765327 hasConcept C2780580376 @default.
• W4386765327 hasConcept C29730261 @default.
• W4386765327 hasConcept C31760486 @default.
• W4386765327 hasConcept C535046627 @default.
• W4386765327 hasConcept C71924100 @default.
• W4386765327 hasConcept C90924648 @default.
• W4386765327 hasConceptScore W4386765327C126322002 @default.
• W4386765327 hasConceptScore W4386765327C141071460 @default.
• W4386765327 hasConceptScore W4386765327C197934379 @default.
• W4386765327 hasConceptScore W4386765327C203092338 @default.
• W4386765327 hasConceptScore W4386765327C2777054765 @default.
• W4386765327 hasConceptScore W4386765327C2777063308 @default.
• W4386765327 hasConceptScore W4386765327C2777583451 @default.

• next